Celyad Oncology SA (CLYYF)

Market Cap	14.76M -28.4%
Revenue (ttm)	24.66K -88.7%
Net Income	974.52K
EPS	0.02
Shares Out	n/a
PE Ratio	15.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,063
Open	0.2500
Previous Close	0.3500
Day's Range	0.2500 - 0.2500
52-Week Range	0.1500 - 0.5300
Beta	1.19
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 23, 2026

About Celyad Oncology

Celyad Oncology SA, a biotechnology company, focuses on unlocking the potential of its intellectual property. Its portfolio comprises multiple foundational US patents focused on TCR-deficient T cell compositions, and it broadly covers allogeneic CAR T cell therapies. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLYYF

Financial Performance

Financial numbers in EUR